Clinical Trial Update: Study of Neoadjuvant Chemotherapeutic Treatment (XELOX) Followed by Chemoradiotherapy (XELOX/RT) and Surgery Versus Chemoradiotherapy Followed by Surgery and Chemotherapy in Patients With High Risk Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing neoadjuvant XELOX followed by chemoradiotherapy and surgery against chemoradiotherapy followed by surgery and chemotherapy in high-risk …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: Sanofi | Conditions: Rectal Neoplasms | Phase 2 | Status: COMPLETED